Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

Bayer hired Pfizer’s Andreas Fibig as ceo of Bayer Schering Pharma;
WuXi PharmaTech hired Richard Soll as vp of medicinal chemistry;
Merck named Leslie Brun, ceo of SARR Group, to its board;
Innocoll named Anthony Wild to its board;
Syntarga named Nitin Damle as an advisor;
Isis Pharmaceuticals hired Marty Bedigian as vp and chief medical officer;
Bristol-Myers Squibb hired Quentin Roach as senior vp and chief procurement officer;
MAP Pharmaceuticals hired Don Kellerman as sr vp, clinical development and medical affairs;
CommonHealth promoted Meaghan Onofrey to president of the MBS/Vox research;
Caraco Pharmaceuticals named Gurpartap Singh Sachdeva to its board;
Safe-BioPharma Assn named Tanya Newton as regulatory affairs and compliance manager;
Human Genome Sciences named Dave Southwell, a former Sepracor exec, to its board;
Horizon Therapeutics hired Tim Walbert as ceo and president, and named him to the board;
Noven Pharmaceuticals hried Joel Lippman as vp of clinical developement and chief medical officer;
Silence Therapeutics says ceo Jeffery Vick has resigned and named Iain Ross as his replacement.